RecruitingPHASE1, PHASE2NCT07439848

Mesenchymal Stem Cells (MSCs) and Conditioned Medium Mesenchymal Stem Cells as Adjuvant Therapy for Sepsis

Studying Adult acute respiratory distress syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
PT. Prodia Stem Cell Indonesia
Principal Investigator
Rima Haifa, B.Sc
Prodia StemCell Indonesia
Intervention
Control (NaCl 0.9%)(other)
Enrollment
15 enrolled
Eligibility
40 years · All sexes
Timeline
20232026

Study locations (1)

Collaborators

Rumah Sakit Pusat Angkatan Darat Gatot Soebroto

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07439848 on ClinicalTrials.gov

Other trials for Adult acute respiratory distress syndrome

Additional recruiting or active studies for the same condition.

See all trials for Adult acute respiratory distress syndrome

← Back to all trials